Sunday, January 08, 2017 10:05:59 PM
Lander has said the company hates dilution but need to pay the bills to advance the science. They believe the dilution is a small sacrifice to the eventual outcome.
My beef with them is the pace of progress. We are waiting now for the exact same news we were waiting for this time last year. DcellVac little progress, Orphan drug status still in limbo. Promising partnerships still unknown.
However all may start coming in together and quickly and someone jumping on board now may have saved themselves a couple years of anguish.
Best regards!
Schuller.
Green Leaf Innovations, Inc. Engages Olayinka Oyebola & Co for Two-Year Audit • GRLF • May 28, 2024 8:30 AM
HealthLynked Introduces AI-Powered Chat Function to Enhance Healthcare Accessibility • HLYK • May 28, 2024 8:00 AM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM